Navigation Links
Researchers gain ground in efforts to fight parasite infection
Date:5/26/2009

DALLAS May 26, 2009 New findings by researchers UT Southwestern Medical Center are accelerating efforts to eradicate worm infections that afflict a third of the world's population.

The new findings, available online and in an upcoming issue of the Proceedings of the National Academy of Sciences, demonstrate that a biochemical system that controls development and reproduction of Caenorhabditis elegans, a common research worm, also provides the same function in several parasitic nematodes, including hookworm.

In these parasitic organisms, the activating molecule, called dafachronic acid, sends the necessary signals for the worms to mature from the stage in which they infect a host to the stage in which they start feeding on the host, which is what makes the host sick. In 2006 UT Southwestern scientists led by Dr. David Mangelsdorf, chairman of pharmacology at UT Southwestern and senior author of the new study in PNAS, had made the discovery in C elegans, a nematode about the size of a pinhead.

In the new study, the UT Southwestern researchers treated hookworm parasites pharmacologically at the infective larval stage with dafachronic acid, causing them to pass into the "feeding" larval stage outside a host, where they had no food supply and died. Treatment of other infectious species had similar effects.

"We essentially coaxed them to mature before a food source the host is available," Dr. Mangelsdorf said.

Many infectious nematode larva live in the soil, often in areas where proper sanitation is lacking. According to the World Health Organization, parasitic nematodes infect about 2 billion people worldwide and severely sicken some 300 million, at least 50 percent of whom are school-age children.

The results point to a promising therapeutic target for the infectious nematodes, said Dr. Mangelsdorf, an investigator with the Howard Hughes Medical Institute at UT Southwestern.

"What keeps these parasites infectious is the lack of production of dafachronic acid," he said. "Once they get inside the host, however, something switches them on to begin making this compound. We can interrupt the worm's life cycle just by giving it this compound when it's in the infectious state, before it enters a host."

The nature of that switch is still under investigation. It may be that the parasite itself somehow senses it is inside the host and begins making the compound, or the parasite could receive a signal from the host to begin production, Dr. Mangelsdorf said. There also is the possibility that the parasite receives the dafachronic acid, or its precursor building blocks, from the host, he said.

Whatever the source of dafachronic acid, the researchers are confident that the compound is worth pursuing as a possible therapeutic target. In the study, the researchers present additional details about the nature of different forms of dafachronic acid and how they function in specific nematodes.

Dr. Mangelsdorf said the next step in the research is to screen large libraries of chemicals to search for compounds that behave like dafachronic acid and that could possibly be developed into pesticides that could be spread in high-infection areas.


'/>"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. Poor attention in kindergarten predicts lower high school test scores, UC Davis researchers find
2. NYU School of Medicine pathology researchers solve another mystery in B lymphocyte development
3. Mayo Clinic Researchers Examine the Psychological Impact of Child Abuse
4. Mayo Clinic researchers examine the psychological impact of child abuse
5. CSI: Mayo Clinic Researchers Find Television Shows Inaccurately Portray Violent Crime
6. Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer
7. Two Targeted Therapies Likely Better Than One in Patients with Aggressive Lymphoma, Mayo Clinic Researchers Say
8. Mayo Clinic Researchers Say Agent Provides Treatment Option for Women with Hot Flashes
9. Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report
10. BUSM researchers find gram-negative rods in two Philippine neonatal intensive care units
11. Mayo Clinic researchers say agent provides treatment option for women with hot flashes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers gain ground in efforts to fight parasite infection
(Date:2/20/2017)... ... February 20, 2017 , ... A new digital ... are called back for additional examinations without sacrificing cancer detection, according to a ... the U.S. Food and Drug Administration approved digital breast tomosynthesis (DBT) for use ...
(Date:2/20/2017)... VA (PRWEB) , ... February 20, 2017 , ... Silverado ... Cambridge Healthcare to open and operate a state-of-the-art memory care community in Alexandria, Virginia. ... 2018 on a site just outside of Old Town. , The three-story community ...
(Date:2/20/2017)... ... February 20, 2017 , ... Clearwave is the ... on the Posiflex XT-series of touch screen terminals. Both companies will be showcasing ... Florida. The terminal provider Posiflex is helping to bridge the gap between healthcare ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... as an employee health benefit for companies that want to help members of ... providers, employees will have access to Watson’s suite of oncology offerings for insights ...
(Date:2/20/2017)... ... February 20, 2017 , ... Chuck E. Cheese’s® and ... Sundays, a joint event at Chuck E. Cheese’s locations throughout New England, New York ... needs, the opportunity to experience the fun of visiting Chuck E. Cheese’s in a ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Feb. 21, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Rosacea Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Rosacea market? ...
(Date:2/20/2017)... Taiwan , Feb. 21, 2017 Taiwan ... leading provider of non-invasive vital signs sensing solutions, today ... industry,s first finger-free wrist pulse oximeter, the oCare TM ... the wearable healthcare and medical devices space.  ... 100, provides a non-invasive, simple and reliable method to ...
(Date:2/20/2017)...  This Report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing ... Forms, and Liquid & Semi-solid Dosage Forms. The report provides separate ... Japan , Europe , ... the full report: http://www.reportlinker.com/p04707109-summary/view-report.html ... Annual estimates and forecasts are provided for ...
Breaking Medicine Technology: